Bonnie B Kim, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4509 Gravel Pike, Green Lane, PA 18054 Phone: 610-348-0402 |
News Archive
Stemedica Cell Technologies , Inc., ("Stemedica"), a world leader in stem cell research and manufacturing (a licensed manufacturer of clinical grade biological products as licensed by the State of California Food and Drug Branch) continues to advance the stem cell industry with the presentation of two of its latest scientific discoveries at the 2009 World Stem Cell Summit.
A new analysis has found that doing away with PSA (prostate specific antigen) testing for prostate cancer would likely cause three times as many men to develop advanced disease that has spread to other parts of the body before being diagnosed. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study suggests that PSA testing and early detection may prevent approximately 17,000 men each year from having such advanced prostate cancer at diagnosis.
Regado Biosciences, Inc., a biopharmaceutical company focused on the late-stage clinical development of its first-in-class, actively controllable antithrombotic drug system, REG1, today announced that the United States Food and Drug Administration has accepted the company's investigational new drug (IND) application for REG2. Regado previously completed a single escalating-dose Phase 1 clinical trial of REG2 and plans to conduct additional clinical testing in sub-acute venous thrombosis indications in the future.
In her latest Kaiser Health News consumer column, Michelle Andrews writes: "When you're calling for an ambulance, chances are good that you won't think to ask for one that's in your health plan's provider network. And in most cases, you wouldn't have much control over who it is anyway. That could leave you with hassles and extra charges for an out-of-network ride".
› Verified 4 days ago